% | $
Quotes you view appear here for quick access.

MiMedx Group, Inc. Message Board

  • tipsmaster tipsmaster Oct 24, 2013 8:58 AM Flag

    woke up to Shires earnings report and found ...

    "Growth in total product sales was moderated by DERMAGRAFT® (down 29% to $24 million), ADDERALL XR® (down 20% to $81 million) and REPLAGAL® (down 11% to $109 million). REPLAGAL product sales continue to be impacted by the return of competition to the Fabry market."
    I think this continues to signal gains in market share for MDXG IMO

7.85-0.31(-3.80%)Feb 5 4:00 PMEST